GGHC
ZSPH

Gilder Gagnon Howe & Co’s ZS PHARMA INC COMS TK (DE) ZSPH Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio ZSPH Stock Details ZSPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-15,366
Closed -$805K – 299
2015
Q2 		$805K Sell
15,366
-89
-0.6% -$4.38K 0.01% 218
2015
Q1 		$650K Sell
15,455
-22
-0.1% -$1.01K 0.01% 217
2014
Q4 		$643K Sell
15,477
-5,396
-26% -$213K 0.01% 216
2014
Q3 		$819K Sell
20,873
-7,337
-26% -$242K 0.01% 216
2014
Q2 		$811K Buy
+28,210
New +$798K 0.01% 228

Other funds holding ZSPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DPA
Devon Park Associates $30.8M AUM 0.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Gilder Gagnon Howe & Co's ZSPH Position: Q3 2015 in Review

Gilder Gagnon Howe & Co sold out of ZS PHARMA INC COMS TK (DE) (ZSPH) in Q3 2015, closing a stake of 15,366 shares — an estimated $805K sold.

Gilder Gagnon Howe & Co first reported a position in ZSPH in Q2 2014 and held it in 5 quarters. The position peaked at $819K in Q3 2014. 124 funds tracked by Wall St. Rank hold ZSPH as of Q3 2015.

  • Gilder Gagnon Howe & Co reported no remaining ZS PHARMA INC COMS TK (DE) position as of Q3 2015 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 15,366 ZS PHARMA INC COMS TK (DE) shares in Q3 2015, an estimated $805K.
  • Gilder Gagnon Howe & Co first reported a position in ZS PHARMA INC COMS TK (DE) in Q2 2014 and held it in 5 quarters.
  • Gilder Gagnon Howe & Co's ZS PHARMA INC COMS TK (DE) position peaked at $819K in Q3 2014.
  • 124 funds tracked by Wall St. Rank held ZS PHARMA INC COMS TK (DE) as of Q3 2015.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2015, filed 9 Nov 2015.